Long‐term prognosis,subsequent pregnancy,contraception and overall management of peripartum cardiomyopathy: practical guidance paper from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy |
| |
Authors: | Karen Sliwa Mark C. Petrie Denise Hilfiker‐Kleiner Alexandre Mebazaa Alice Jackson Mark R. Johnson Peter van der Meer Amam Mbakwem Johann Bauersachs |
| |
Affiliation: | 1. Hatter Institute for Cardiovascular Research in Africa, Department of Medicine & Cardiology, Faculty of Health Sciences, University of Cape Town, South Africa;2. Mary McKillop Institute, ACU, Melbourne, Australia;3. Golden Jubilee National Hospital, Glasgow, UK;4. Department of Cardiology and Angiology, Medizinische Hochschule Hannover, Hannover, Germany;5. H?pital Lariboisière, Université Paris Diderot, Inserm U942, Paris, France;6. Department of Obstetrics, Imperial College School of Medicine, Chelsea and Westminster Hospital, London, UK;7. Department of Cardiology, University Medical Center Groningen, Groningen, The Netherlands;8. Department of Cardiology, Lagos University Hospital, Lagos |
| |
Abstract: | Peripartum cardiomyopathy is an idiopathic cardiomyopathy presenting with heart failure secondary to left ventricular systolic dysfunction towards the end of pregnancy or in the months following delivery, where no other cause for heart failure is identified. Outcome varies from full recovery to residual left ventricular systolic dysfunction and even death. Many women return to their physician to acquire information on their long‐term prognosis, to seek medical advice regarding contraception, or when planning a subsequent pregnancy. This position paper summarizes current evidence for long‐term outcome, risk stratification of further pregnancies and overall management. Based on the best available evidence, as well as the clinical experience of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy members, a consensus on pre‐ and postpartum management algorithms for women undergoing a subsequent pregnancy is presented. |
| |
Keywords: | Peripartum cardiomyopathy Subsequent pregnancy Mortality |
|
|